🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 30% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
90 Servings
Other Combinations Product Type
30% Evidence Coverage

Supplement Facts — Evidence Check

10 mg (50% DV)
✅ Within RDA (0.7× RDA of 14 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 10mg UL 35mg
5 mg (250% DV)
📊 3.8× RDA — above typical dose (UL: 100 mg) 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 5mg UL 100mg
100 mcg (1667% DV)
📊 41.7× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.1mg
5 mg (50% DV)
✅ Within RDA (1.0× RDA of 5 mg) 📚 1 studies — no high-quality reviews
RDA 5mg This product: 5mg
Intensify Xtreme Proprietary Blend
683 mg
Thermo-Lean Blend
Insul-Lean Blend
De-Fine Water Loss Blend
Thyro-Cut Complex
Thermo-Sorb Delivery Blend

Other Ingredients

Gelatin Microcrystalline Cellulose Magnesium Stearate FD&C Blue 1 FD&C Red 40 Titanium Dioxide

Label Claims — Verification

All Other
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

SUGGESTED USE FOR STACK: With 6-8 oz. of juice or water take 1 Intensify(R) XTREME capsule 30 minutes prior to your morning meal and 1 capsule 30 minutes prior to your afternoon meal.

⚠️ Warnings & Precautions

WARNING: KEEP OUT OF REACH OF CHILDREN.

Do not use for more than 8 weeks.

Consult with your physician prior to use if you are taking medication, including but not limited to MAOI inhibitors, antidepressants, aspirin, blood thinning medications, nonsteroidal anti-inflammatory drugs or products containing phylephrine, ephedrine, pseudoepherine, or other stimulants.

Consult your physician prior to use if you have a medical condition, including but not limited to, heart, liver, kidney, or thyroid disease, psychiatric or epileptic disorders, difficulty urinating, diabetes, high or low blood pressure, cardiac arrhythmia, recurrent headaches, enlarged prostate or glaucoma. Do not use if you are prone to dehydration or exposed to excessive heat. Discontinue use 2 weeks prior to surgery or if you experience rapid heartbeat, dizziness, severe headache or shortness of breath or upset stomach. Do not use if tamper evident seal is broken.

Intensity(R) XTREME and Censor(R) are not intended for use buy those under the age of 18.

Do not use this product if you are pregnant or nursing.

Do not use if allergic or contraindicated to aspirin.

Before consuming seek advice from a health care professional if you are unaware of your current health condition.

Do not consume synephrine or caffeine from other sources, including but not limited to, coffee, tea, soda, and other dietary supplements or medications containing phenylephrine or caffeine.

Do not exceed recommended dose.

🧪 Formulation Notes

Contains caffeine.

Includes: Raspberry Ketones Bacopa Monnieri Cinnulin PF(R)

Additional Information

STORE IN A COOL DRY PLACE. AVOID EXCESSIVE HEAT.

FAT BURNING STRONG THERMOGENIC DROP THE POUNDS!

To be used as part of a healthy lifestyle consisting of regular physical activity and a proper diet.

Support for: Energy/Focus/Fat Loss Diuretic/Appetite Control

MULTI-DIMENSIONAL WEIGHT LOSS HEALTHY WEIGHT LOSS KIT

INTENSIFY(R) Xtreme

Product Details

DSLD Entry Date 2014-04-25
Product Type Other Combinations
Form Capsule
Brand NDS
Bundle Dual Impact Stack
DSLD ID 32389
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →